Viewing nowGlimepide Tablet 1 mg (Glimiperide)
Glimepiride 1mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200402623 · Notified 2004.09.24 · Insurance code 643500110
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone, but if control is difficult with oral hypoglycemic agents, it may be used in combination with insulin, or with metformin when the use of sulfonylureas and metformin alone is insufficient. This medication effectively regulates blood sugar levels, aiding in the management of diabetes.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions given under Initial Dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. Consider the potency and duration of action of the previously administered medicine. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly corrected by taking sugar. Hypoglycemia may recur after initial successful management with a sulfonylurea. Therefore, patients should be observed carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodically adjust the insulin dose while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may be increased. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Avoid use if there is an allergy to this medication, its components, or sulfonylureas. Since it contains lactose, it should not be administered to patients with galactose intolerance or lactose deficiency. Patients with severe liver or kidney impairment should not use this medication, and switching to insulin therapy is recommended. It is safest for women who are pregnant or may become pregnant, and for breastfeeding women, to avoid this medication. In cases of severe infection, before and after surgery, or in cases of severe trauma, insulin therapy is preferred. In the case of gastrointestinal disturbances such as diarrhea or vomiting, there is a risk of hypoglycemia due to inadequate food absorption and caution is advised. During the first week of administration, the risk of hypoglycemia is high, and blood sugar levels should be closely monitored, especially in the elderly, those with poor nutritional status, irregular eating patterns, or those who consume alcohol. Imbalances in muscle exercise and carbohydrate intake, as well as kidney and liver function impairments or endocrine diseases, can also increase the risk of hypoglycemia, so caution is advised. Additionally, when used in combination with other medications, there may be interactions that affect blood sugar control, so consultation with a doctor or pharmacist is essential. Patients allergic to Tartrazine (Yellow No. 5) should also use this medication cautiously. This medication can cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. Hypoglycemia can be quickly addressed by consuming sugar, so patients are advised to always carry sugar with them. Initial treatment may lead to blurred vision, gastrointestinal symptoms, liver function abnormalities, blood abnormalities, or allergic reactions; if any concerning symptoms arise, the healthcare provider should be notified immediately. Severe allergic reactions or severe hypoglycemia can be life-threatening and require immediate medical attention. This medication should be taken in conjunction with a regular diet and exercise regimen, and blood sugar control should be routinely monitored. In particular, during stressful situations, surgery, or infections, blood sugar control may become more challenging, and switching to insulin therapy may be necessary. Additionally, caution is needed when driving or operating machinery while taking this medication. This medication can interact with other drugs, so patients must inform their healthcare provider of any other medications they are taking, especially when using CYP2C9-related drugs, beta-blockers, or alcohol. Pregnant or breastfeeding women should refrain from using this medication due to potential effects on the fetus and newborn, and insulin therapy should be considered as needed. The safety and efficacy in children under 18 years of age have not been established, and its use is not recommended. Elderly patients may have decreased kidney function, so careful dose adjustment is necessary. In the event of an overdose, hypoglycemic symptoms may appear, and immediate notification to a healthcare provider is necessary, and emergency measures such as gastric lavage or intravenous glucose may be required. This medication should be stored out of reach of children and kept in its original container for safety.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, elevated liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to store the medication at room temperature between 1°C and 30°C. Proper storage preserves the medication’s efficacy and safety.
Pale pink oblong tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 1mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.